Target intelligence / Profile preview

Violacein biosynthesis protein VioB (VioB)

Target
VioB
Molecular classification
Enzyme, Oxidase, Heme-dependent enzyme
01

Overview

Violacein biosynthesis protein VioB is a critical enzyme in the biosynthetic pathway of violacein, a bis-indole pigment produced by various bacteria, most notably Chromobacterium violaceum [1, 2]. As a heme-dependent oxidase, VioB catalyzes the dimerization of two indole-3-pyruvic acid (IPA) imine molecules, a key step in constructing the complex pyrrolidone-containing scaffold of violacein [2, 31]. This enzyme is of significant interest in biotechnology and medicine due to the potent biological activities of its product, violacein, which exhibits antibacterial, antifungal, and antitumoral properties [3, 35]. VioB is considered a therapeutic target for anti-virulence strategies aimed at reducing the toxicity of C. violaceum, an opportunistic human pathogen, as its inhibition leads to the depletion of violacein and a subsequent decrease in bacterial virulence [5]. Additionally, VioB is a primary focus for metabolic engineering efforts to enhance the microbial production of violacein for pharmaceutical applications [2, 35].

Other names
Iminophenyl-pyruvate dimer synthaseIPA imine dimer synthaseL-tryptophan 2-aminotransferase (misnomer)VioB protein
02

Mechanism of action

Catalyzes the oxidative coupling and dimerization of two molecules of indole-3-pyruvic acid (IPA) imine to form a precursor of violacein.

03

Biological functions

Violacein biosynthesisSecondary metabolismIndole metabolism
04

Disease associations

InfectionCancer
05

Safety considerations

Potential off-target effects on human heme-containing enzymesReduction in beneficial bacterial secondary metabolites
06

Biomarkers

Violacein productionPurple pigmentation

Beyond the preview

Go deeper on Violacein biosynthesis protein VioB (VioB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Violacein biosynthesis protein VioB (VioB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call